SFTPA1 Peptide

SPA, PSAP, PSPA, SP-A, SPA1, PSP-A, SFTP1, SP-A1, COLEC4, SFTPA1B, SFTPA, Pulmonary surfactant-associated protein A1, 35 kDa pulmonary surfactant-associated protein

SFTPA1 Peptide is used for blocking the activity of SFTPA1 Antibody (catalog number 42-993). SFTPA1 antibody ships at 0.5 mg/mL and the IRF4 Peptide ships as a 100 μg pellet. When peptide is reconstituted in 200 μL water, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.

SFTPA1 peptide is supplied as 100 μg of dried peptide. When the peptide is reconstituted in 200 μL water, the concentration will be 0.5 mg/mL.

653509

surfactant protein A1

SFTPA1

Homo sapiens

SFTPA1 peptide is a 14 amino acid synthetic peptide near the internal region of SFTPA1 (aa 102-115).

Lyophilized

NP_005402.3; NP_001087239.2; NP_001158117.1; NP_001158118.1; NP_001092138.1

38888175

Q8IWL2